Dissociation of sarcoglycans and the dystrophin carboxyl terminus from the sarcolemma in enteroviral cardiomyothy

Circulation Research

Volumn 87, Issue 6, 2000, Pages 489-495

  Lee, Gil Hwan ^a,b   Badorff, Cornel ^a,c   Knowlton, Kirk U ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b The Catholic University of Korea   (South Korea)

^c GOETHE UNIVERSITY   (Germany)

Author keywords

Cardiomyopathy; Coxsackievirus; Heart failure; Myocarditis; Sarcoglycans

Indexed keywords

DYSTROPHIN; MEMBRANE PROTEIN; SARCOGLYCAN;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CARDIOMYOPATHY; COXSACKIE VIRUS; DISSOCIATION; HEART FAILURE; HEART MUSCLE FIBER MEMBRANE; MALE; MEMBRANE BINDING; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; RAT; VIRUS MYOCARDITIS;

EID: 0034665285     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.87.6.489     Document Type: Article

References (43)

1. Muscular dystrophies and the dystrophin-glyco-protein complex
2. Sarcospan, the 25-kDa transmembrane component of the dystrophin-glycoprotein complex
3. Complexity in simplicity: Monogenic disorders and complex cardiomyopathies
4. The sarcoglycan complex in limb-girdle muscular dystrophy
5. Disruption of heart sarcoglycan complex and severe cardiomyopathy caused by β sarcoglycan mutations
6. Brief report: Deficiency of a dystrophin-associated glycoprotein adhalin in a patient with muscular dystrophy and cardiomyopathy
7. Heart involvement in muscular dystrophies due to sarcoglycan gene mutations
8. The heart in limb girdle muscular dystrophy
9. Identification of the Syrian hamster cardiomyopathy gene
10. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
11. Disruption of the β-sarcoglycan gene reveals pathogenetic complexity of limb-girdle muscular dystrophy type 2E
12. γ-Sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin
13. Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy
14. Dystrophinopathy, the expanding phenotype: Dystrophin abnormalities in X-linked dilated cardiomyopathy
15. Brief report: Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy
16. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy
17. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure
18. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
19. The role of cytoskeletal proteins in cardiomyopathies
20. Etiologies of cardiomyopathy and heart failure
21. Coxsackie B viruses and human heart disease
22. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction
23. Viral myocarditis: A paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy
24. Transgenic expression of replication-restricted enteroviral genomes in heart muscle induces defective excitation-contraction coupling and dilated cardiomyopathy
25. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
26. Enteroviral protease 2A directly cleaves dystrophin and is inhibited by a dystrophin-based substrate analogue
27. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle
28. Dp71 can restore the dystrophin-associated glycoprotein complex in muscle but fails to prevent dystrophy
29. Exogenous Dp71 restores the levels of dystrophin associated proteins but does not alleviate muscle damage in mdx mice
30. Disruption of the dystrophin-glycoprotein complex in the cardiomyopathic hamster
31. A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of CVB3
32. Enteroviral infection of mice with severe combined immunodeficiency: Evidence for direct viral pathogenesis of myocardial injury
33. Transfer of human myocarditis into severe combined immunodeficiency mice
34. + T lymphocytes in coxsackievirus B3-induced myocarditis
35. An epitope structure for the C-terminal domain of dystrophin and utrophin
36. Purification of dystrophin from skeletal muscle
37. NF κB-mediated inhibition of apoptosis is required for encephalomyocarditis virus virulence: A mechanism of resistance in p50 knockout mice
38. Molecular organization of sarcoglycan complex in mouse myotubes in culture
39. Molecular pathogenesis of muscle degeneration in the δ-sarcoglycan-deficient hamster
40. Animal models for muscular dystrophy show different patterns of sarcolemmal disruption
41. Dystrophins in vertebrates and invertebrates
42. A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other non-muscle tissues
43. Assembly of the sarcoglycan complex: Insights for muscular dystrophy